1. smithat9474
2. pa838
3. ryder69398
4. stangboy0610
1.pa838 03/05/2018
Dead on arrival
2.smithat9474 02/01/2018
Dermira Initiates Phase 2b Dose-Ranging Study Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis
3.smithat9474 02/22/2018
Misses EPS loss estimates by $0.12. Slightly beats on revenues.
4.pa838 03/05/2018
Dermira’s Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet…
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW